Repeated administration of mirtazapine attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B up-regulation in rats

Neurochemical Research

Volumn 38, Issue 9, 2013, Pages 1973-1979

  Liu, Xiaoyu ^a   Zhang, Guangfen ^b   Dong, Lin ^b   Wang, Xingming ^b   Sun, Heliang ^b   Shen, Jinchun ^a,b   Li, Weiyan ^a,b   Xu, Jianguo ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

5 HT1A receptor; Mirtazapine; Neuropathy; NR2B; Oxaliplatin

Indexed keywords

MIRTAZAPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXALIPLATIN; SEROTONIN 1A RECEPTOR;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; HYPERALGESIA; MALE; NONHUMAN; PERIPHERAL NEUROPATHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; ROTAROD TEST; UPREGULATION;

RATTUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HYPERALGESIA; MIANSERIN; ORGANOPLATINUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPINE; UP-REGULATION;

EID: 84881474884     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1103-3     Document Type: Article

References (30)

1. Ling B, Authier N, Balayssac D, Eschalier A, Coudore F (2007) Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128:225-234
2. Saif MW, Reardon J (2005) Management of oxaliplatin-induced peripheral neuropathy. Ther Clin Risk Manag 1:249-258
3. Yamamoto T, Shimoyama N, Asano H, Mizuguchi T (1994) Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat. Anesthesiology 80:1311-1319
4. Yamamoto T, Yaksh TL (1992) Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve excitatory amino acid antagonists. Pain 49:121-128
5. Mihara Y, Egashira N, Sada H, Kawashiri T, Ushio S, Yano T, Ikesue H, Oishi R (2011) Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol Pain 7:8
6. Sakurai M, Egashira N, Kawashiri T, Yano T, Ikesue H, Oishi R (2009) Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain 147:165-174
7. Gilron I, Watson CP, Cahill CM, Moulin DE (2006) Neuropathic pain: a practical guide for the clinician. Can Med Assoc J 175:265-275
8. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH (1988) Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 38:1427-1432
9. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, Coderre T, Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman GB, Velly A (2007) Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12:13-21
10. De Boer T (1996) The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clinic Psychopharmacol 10:19-23
11. Bomholt SF, Mikkelsen JD, Blackburn-Munro G (2005) Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48:252-263
12. Freynhagen R, Vogt J, Lipfert P, Muth-Selbach U (2006) Mirtazapine and its enantiomers differentially modulate acute thermal nociception in rats. Brain Res Bull 69:168-173
13. Zhu J, Wei XW, Feng XM, Song J, Hu YM, Xu JG (2008) Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-κB in a rat model of neuropathic pain. Neurosci Lett 433:33-37
14. Schreiber S, Bleich A, Pick CG (2002) Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects - a possible opioid involvement in severe depression. J Mol Neurosci 18:143-149
15. Schreiber S, Rigai T, Katz Y, Pick CG (2002) The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull 58:601-615
16. Szegedi A, Schwertfeger N (2005) Mirtazapine: a review of its clinical efficacy and tolerability. Expert Opin Pharmacother 6:631-641
17. Martel JC, Assié MB, Bardin L, Depoortère R, Cussac D, Newman-Tancredi A (2009) 5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception. Br J Pharmacol 158:232-242
18. Viisanen H, Pertovaara A (2010) Roles of the rostroventromedial medulla and the spinal 5-HT1A receptor in descending antinociception induced by motor cortex stimulation in the neuropathic rat. Neurosci Lett 476:133-137
19. Yamamura S, Abe M, Nakagawa M, Ochi S, Ueno S, Okada M (2011) Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions. Neuropharmacology 60:550-560
20. Necker R, Hellon RF (1978) Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain 4:231-242
21. Blackburn-Munro G, Bomholt SF, Erichsen HK (2004) Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 47:351-362
22. Coimbra NC, De Oliveira R, Freitas RL, Ribeiro SJ, Borelli KG, Pacagnella RC, Moreira JE, Silva LA, Melo LL, Lunardi LO, Brandão ML (2006) Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia. Exp Neurol 197:93-112
23. Yuen EY, Jiang Q, Chen P, Gu Z, Feng J, Yan Z (2005) Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J Neurosci 25:5488-5501
24. Doly S, Madeira A, Fischer J, Brisorgueil MJ, Daval G, Bernard R, Vergé D, Conrath M (2004) The 5-HT2A receptor is widely distributed in the rat spinal cord and mainly localized at the plasma membrane of postsynaptic neurons. J Comp Neurol 72:496-511
25. Jaggi AS, Singh N (2011) Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol Disord Drug Targets 10:589-609
26. 2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat. Pain 140:305-322
27. 1A regulation of N-Methyl-d-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J Biol Chem 283:17194-17204
28. Kawashiri T, Egashira N, Kurobe K, Tsutsumi K, Yamashita Y, Ushio S, Yano T, Oishi R (2012) L type Ca2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 over expression in rats. Mol Pain 8:7
29. Deuis JR, Zimmermann K, Romanovsky AA, Possani LD, Cabot PJ, Lewis RJ, Vetter I (2013) An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways. Pain. doi: 10.1016/j.pain.2013.05.032
30. Durand JP, Brezatilt C, Goldwasser F (2003) Protection against oxaliplatin acute neurosensory toxicity by venlafaxine. Anticancer Drugs 14:423-425